FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
February 02, 2006
Commission File Number 001-14978
SMITH & NEPHEW plc
(Registrant's name)
15 Adam Street
London, England WC2N 6LA
(Address of registrant's principal executive offices)
[Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.]
Form 20-F X Form 40-F
--- ---
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1).]
Yes No X
--- ---
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7).]
Yes No X
--- ---
[Indicate by check mark whether by furnishing the information contained
in this Form, the registrant is also thereby furnishing information to the
Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of
1934.]
Yes No X
--- ---
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2 (b) : 82- n/a.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Smith & Nephew plc
(Registrant)
Date: February 02, 2006
By: /s/ Paul Chambers
-----------------
Paul Chambers
Company Secretary
Smith & Nephew - Finance Director Appointment
2 February 2006
Smith & Nephew plc (LSE: SN, NYSE: SNN) the global medical technology business
announces today that after 15 years as Finance Director Peter Hooley will retire
in mid 2006. Peter has made a major contribution to the development of the
business, both strategically and financially. The board is deeply appreciative
of his dedication to the business and his achievements in increasing shareholder
value.
The Board has conducted a thorough search process and is pleased to announce
that Adrian Hennah, currently Chief Financial Officer of Invensys plc, will be
appointed to the board as Finance Director in June 2006.
Chris O'Donnell, Chief Executive of Smith & Nephew commenting on this
appointment said "Peter and I have worked closely together since he first joined
Smith & Nephew and in particular during the successful restructuring of the
Group. His wise counsel and deep understanding of the business have played a
major part in growing Smith & Nephew into a worldwide leader in the medical
devices sector.
Adrian Hennah has all the characteristics we were looking for in a new Finance
Director. He brings a combination of industrial and international experience,
as well as deep financial skills. I welcome Adrian to the Board, to Smith &
Nephew, and the talent and strength he will bring."
There are no details relating to the appointment of Adrian Hennah that are
required to be disclosed pursuant to paragraph 9.6.13 (1-6) of the Listing
Rules.
Enquiries
Investors
Sir Christopher O'Donnell Tel: +44 (0) 20 7401 7646
Group Chief Executive
Smith & Nephew
Investors / Media
Liz Hewitt Tel: +44 (0) 20 7401 7646
Group Director Corporate Affairs
Smith & Nephew
About Adrian Hennah
Adrian Hennah (47) MA (Cantab) qualified with Price Waterhouse and worked as a
management consultant for them before joining Glaxo in 1984 where his early
roles included UK Finance and IT Director. He continued his career at Glaxo as
General Manager at Allen & Hanbury's and Director of Glaxo UK then acting as the
global integration team leader for the Glaxo and Wellcome merger. Following
this he then spent some time based in the US as SVP Finance and Operations for
the research and development operations of the merged business before becoming
Chief Financial Officer of Glaxo Wellcome Inc. During the merger with SmithKline
Adrian jointly led the integration team before becoming SVP Finance for
GlaxoSmithKline R&D in 2001. He joined Invensys plc as Chief Financial Officer
in 2002.
About Smith & Nephew
Smith & Nephew is a global medical technology business, specialising in
Orthopaedics, Endoscopy and Advanced Wound Management products. Smith & Nephew
is a global leader in arthroscopy and advanced wound management and is one of
the fastest growing global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The company
prides itself on the strength of its relationships with its surgeons and
professional healthcare customers, with whom its name is synonymous with high
standards of performance, innovation and trust. The company has over 8,500
employees and operates in 33 countries around the world generating annual sales
of GBP1.25 billion.